Published in Immunotherapy Weekly, October 11th, 2006
According to a study from Japan, "The effects of sevoflurane on proinflammatory cytokines related to ischemic-reperfusion injury are not clear. The hypothesis was tested that sevoflurane decreases myocardial ischemic-reperfusion injury by suppressing proinflammatory cytokines. This was a prospective, randomized study conducted at a medical university heart center."
T. Kawamura and colleagues, Sendai Medical Center, explained, "Twenty-three patients undergoing coronary artery by-pass surgery were allocated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.